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Background
PAN is a systemic vasculitis with multisystem involve-
ment rarely observed in childhood. We report two siblings
(1 boy, 1 girl) with aggressive PAN who had a persistent
sustained improvement with MMF.
Patients
The boy developed at 8 yrs musculoskeletal pain and
painful nodules on the legs, than vertigo, tinnitus, and
diplopia, neurosensorial ipoacusia, left central facial palsy
and hypertension. Angio MRI revealed ischemic altera-
tions on Willis's circle and prompted to diagnose PAN.
Despite aggressive therapy the boy developed ischemic
lesions of 3 digits of hands and Iloprost was introduced;
over a short time multiple ulcerative deep cutaneous
lesions appeared on the legs. Due to persistent active dis-
ease, MMF (2 g/day) was started and up to now the clini-
cal symptoms are stable and laboratory work up
normalised.
The girl, at 30 months had neurological manifestations
(head and eye rotation with no consciousness, optical
bilateral neuritis); over time similar episodes recurred and
periodic ataxia was diagnosed. Cerebral MRI showed areas
of hyperintensity on the thalamus. At 7 yrs maculopapu-
lar rash on the face and upper extremities, arthralgia/mial-
gia and hypertension were complained. Skin biopsy
confirmed necrotizing vasculitis of medium sided vessels
and PAN was diagnosed. Deep cutaneous ulcers appeared
on the legs. After a severe ischemic attack, confirmed by
MRI lesions at the pons area, MMF was started. Since then
the girl is stable.
Conclusion
MMF used in the treatment of SLE and primary vasculitis
in children, should be considered as either alternative or
adjunctive therapy in intractable severe persistent active
PAN.
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